News

10/17/2023

Jefferson Lab to Lead $300+ Million High Performance Data Facility Hub

The U.S. Department of Energy has just announced the selection of Thomas Jefferson National Accelerator Facility as the lead for its new High Performance Data Facility Hub. Jefferson Lab will partner with DOE’s Lawrence Berkeley National Laboratory to form a joint project team led by Jefferson Lab. The HPDF will be a $300-500 million computing

10/11/2023

IndoUSrare Announces Bridging RARE Summit to Combat Rare Diseases by Fostering Cross-Border Collaborations, Data Sharing, and Clinical Trials

Rare diseases, as defined by the World Health Organization (WHO), refer to some 10,867 medically significant conditions, each with a prevalence of one or less per 1,000 individuals. With only about 8% of them being treatable,1 rare diseases include congenital malformations, autoimmune disorders, lysosomal storage disorders, thalassemia, muscular dystrophies, and infrequent forms of cancer and

10/10/2023

The Success of the 8th Women Building Bio Conference “Building Better” Promises Women Will Thrive in Life Sciences

The 8th Women Building Bio, Virginia Bio’s annual conference, held in Manassas, VA, on September 28, gathered over 100 life sciences professionals who convened to exchange knowledge, share experiences, and explore innovative approaches that help women thrive in the field. The fact that this year’s conference theme, “Building Better,” attracted everyone from life science students

10/09/2023

CIVCO Radiotherapy and Qfix Launch CQ Medical Brand

CIVCO Radiotherapy and Qfix announced today the launch of a new brand, CQ Medical. This brand reflects the company’s vision and global leadership in high-quality, patient-centric radiotherapy solutions and more than 80 years of combined experience. CQ Medical marks a pivotal transformation for CIVCO Radiotherapy and Qfix, who joined forces in October 2022. Under its

10/04/2023

Life Sciences Leaders, Advocates Launch New Partnership to Promote Benefits of Pro-Innovation Mergers & Acquisitions

More than thirty leading organizations from across the life sciences today launched the Partnership for the U.S. Life Science Ecosystem (PULSE), a coalition to raise awareness of the fundamental role of pro-innovation mergers and acquisitions (M&A) in advancing the next generation of treatments and cures for patients. The U.S. is home to thousands of life

09/28/2023

Governor Glenn Youngkin Announces Over $3.7 Million in Growth and Opportunity for Virginia Grants

Governor Glenn Youngkin announced today more than $3.7 million in Growth and Opportunity for Virginia (GO Virginia) grant awards for 11 projects designed to empower workforce development, bolster startup ecosystems and promote economic growth in the Commonwealth. These initiatives will play a pivotal role in nurturing skilled talent, fostering entrepreneurial ventures and bridging the gap

09/22/2023

State public health laboratory, Henrico County Schools launch pilot program to promote life science career

More than 50 Henrico County high school students and teachers joined scientists from Virginia’s public health and environmental laboratory Wednesday to kick off an innovative program that brings together private and government scientists and experts, business and nonprofit leaders, and public schools to explore ways to create a pipeline of talent to fuel Virginia’s growing

09/21/2023

Climate Tech Startup ThermaGEL Innovations’ Breakthrough Aerogels Join the Challenge to Save Half-Gigaton of C02 Emissions Each Year

In the fight against climate change, properly insulating homes and buildings can significantly raise energy efficiency and indoor air quality while lowering carbon dioxide emissions. A startup company, spun out of research at Virginia Commonwealth University, is commercializing what it calls a breakthrough in low-cost insulation materials. ThermaGEL Innovations has developed insulation material using aerogels,

09/20/2023

Charlottesville healthy sugar innovator Bonumose raises $2M

Bonumose Inc., a Charlottesville startup specializing in table sugar alternatives, has raised $2 million toward a $10 million funding round after German flavor and fragrances producer Symrise AG signed a minority investment agreement with the company. “The strategic investment from Symrise is part of a larger funding round that will be used for increasing sales,

09/20/2023

FDA awards nearly $7.5 million to pediatric device consortium led by Children’s National Hospital

To foster the development and commercialization of medical devices designed for children, the Food and Drug Administration (FDA) has awarded a nearly $7.5 million grant to the Alliance for Pediatric Device Innovation (APDI), a consortium led by Children’s National Hospital. The nonprofit group, which is one of five in the FDA’s Pediatric Device Consortia (PDC) program,

09/14/2023

Three Virginia Universities Land on Top Patents List

Three Virginia research universities have made the National Academy of Inventors’ new list ranking the nation’s universities that were granted the most patents in 2022. The University of Virginia, Virginia Commonwealth University and George Mason University each made the list released Aug. 30, ranking 43rd, 86th and 91st respectively. U.Va. had 52 patents issued in

09/14/2023

5 Excellent Finalists Chosen for the 8th Annual BioHealth Capital Region Crab Trap

BioHealth Innovation, Inc. (BHI), a leading regional innovation intermediary, is thrilled to announce the five outstanding finalists for the 8th Annual BioHealth Capital Region Crab Trap competition. The Crab Trap is a competition designed to identify and showcase promising life sciences and biotechnology startups from around the world. These finalists have demonstrated exceptional innovation, vision,

09/12/2023

Ceres Nanosciences and Ginkgo Bioworks Partner to Bring Pathogen Monitoring Capabilities to Labs Around the World

Ceres Nanosciences, a global leader in developing wastewater testing methods based on its Nanotrap® technology, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that they are partnering to bring pathogen monitoring capabilities to laboratories around the world. Pathogen monitoring and analysis capabilities, including in wastewater,

09/12/2023

Virginia Coordinated Clinical Research Network Launched to Focus on Clinical Trial Research, Developing Medical Treatments, Scientific Advancements, and Real-World Applications

From the development of new medicines and cancer treatments to gene therapy and advances in scientific understanding of serious conditions such as Alzheimer’s disease, clinical research is helping drive the future of medical innovation and patient care. To further support that work, a coalition of health care systems, institutions of higher education, and other organizations

09/12/2023

VT Fralin Biomedical Research Institute Receives $50M Gift

A foundation established by the estate of Richmond philanthropist Bill Goodwin‘s late son, Hunter, has made a $50 million commitment to support cancer and neuroscience research at the Fralin Biomedical Research Institute at VTC, Virginia Tech announced Tuesday. The gift is one of three record $50 million donations Virginia Tech has received, including the 2018

09/08/2023

BEAM receives $1.84 million NIH grant to improve preventative screening for opioid use disorder in partnership with UVA Health

BEAM Diagnostics, Inc. (BEAM), a behavioral health company delivering digital assessments to improve patient-centered healthcare – has been awarded a $1.84 million grant from the National Institutes of Health (NIH) to commercialize its pioneering technology, improving and increasing proactive assessment of opioid use disorder in outpatient medical clinics. BEAM’s proprietary technology, Beacon-OUD, is a digital

09/06/2023

Probiotic Study Shows Promise on Improving Innate Immunity

BIO-CAT, Inc,  | BIO-CAT announced that a newly published study on the probiotic Bacillus subtilis MB40 revealed promising results leading to the reduction of Listeria. The study was designed to determine the effects of Bacillus subtilis MB40 supplementation on innate immunity and Listeria. This study was completed in partnership with the School of Animal Sciences at

09/05/2023

AgroSpheres Novel Encapsulation Platform Now Listed by Organic Materials Review Institute (OMRI) for Use in Organic Crop Production

AgroSpheres, Inc., an agricultural biobased solutions developer, is pleased to announce that its proprietary encapsulation technology, AgroSpheres® Microbially-Derived Minicells (also known as the AgriCell), was recently reviewed by the Organic Materials Review Institute (OMRI), which has determined that it meets the criteria for use under the USDA National Organic Program (NOP). AgroSpheres® Microbially-Derived Minicells is

08/31/2023

VIPC’s Robert Stolle Announces Plans to Step Down From His Role as President and CEO

The Virginia Innovation Partnership Corporation (VIPC) announced that Robert Stolle plans to step down from his role as President and CEO. Stolle has been with VIPC and its predecessor – The Center for Innovative Technology (CIT) – for 13 years, including serving the last 3 as CEO. Prior to his current role, he was Senior

08/15/2023

VIPC Regional Innovation Fund Grant Awarded to CvilleBioHub to Strengthen the Entrepreneurial Ecosystem in Region

CvilleBioHub, an industry-led 501c3 nonprofit organization dedicated to accelerating Charlottesville’s biotechnology industry sector, today announced that it has again received a $200,000 Regional Innovation Fund (RIF) grant from the Virginia Innovation Partnership Corporation. RIF is state-funded program that provides competitive grants to leading Virginia-based entrepreneur support organizations. CvilleBioHub sits at the center of a thriving

08/10/2023

Activation Capital seeking anchor tenant for forthcoming downtown Richmond innovation center

Activation Capital is seeking an anchor tenant for its planned 102,000-square-foot, $53 million innovation center and is looking to Under Armour’s corporate campus in Baltimore and Capital One’s 1717 Michael Wassmer Innovation Center in Richmond for inspiration. The building, to be located in Activation Capital’s VA Bio+Tech Park in Richmond, has been planned for 20

08/09/2023

Virginia Tech joins with universities, bioscience companies to address health care needs

With funding from Virginia Catalyst, also known as the Virginia Biosciences Health Research Corp., Virginia Tech is engaged in three collaborative bioscience projects to address unmet health care needs in Virginia, according to Michael Friedlander, vice president for health sciences and technology at Virginia Tech. The Catalyst awards, which range from $350,000 to $800,000, support joint research projects between industry and Virginia universities

08/01/2023

ReAlta Doses First Patient in Phase 2 STAR Study of RLS-0071 for HIE in Newborns

ReAlta Life Sciences (“ReAlta”), Inc., a clinical mid-stage biotech company dedicated to addressing life-threatening rare diseases by harnessing the power of the immune system,  announced dosing of the first patient in a Phase 2 clinical trial evaluating the safety and efficacy of RLS-0071 for the treatment of hypoxic ischemic encephalopathy (HIE) in newborns. RLS-0071, an

07/27/2023

RIVANNA receives $30.5 million from BARDA to advance the Accuro XV musculoskeletal imaging system

RIVANNA®, developers of imaging-based medical solutions, announced that they have received funding totaling $30.5 million over 39 months from early execution of an option by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The funding